{"id":4467,"date":"2020-08-26T09:20:23","date_gmt":"2020-08-26T09:20:23","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/rapid-test-for-dengue\/"},"modified":"2021-01-08T11:29:33","modified_gmt":"2021-01-08T11:29:33","slug":"rapid-test-for-dengue","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/rapid-test-for-dengue\/","title":{"rendered":"Rapid test for dengue"},"content":{"rendered":"
Dengue, a disease occurring in tropical and sub-tropical areas, is transmitted by the bites of Aedes <\/i>mosquitoes infected with dengue viruses. The resulting dengue fever is a febrile illness that affects all age groups, and it can progress to dengue haemorrhagic fever, which is a potentially lethal complication mainly affecting children. The ASSURE Dengue IgA Rapid Test facilitates diagnosis of dengue-infected patients. It is an indirect solid-phase immunochromatographic assay, where antibodies in the test sample (serum, plasma or whole blood) form antibody-antigen complexes with immobilised antigen on the membrane as the test sample migrates upwards from the sample well. The bound antibody-antigen complexes are subsequently detected by anti-human IgA conjugated to colloidal gold. The control line contains protein L, which binds with human IgA and the anti-human IgA-colloidal gold conjugate. Results are available within 20 minutes. The test kit includes the test device, sample applicator and buffer.
\n
\nSupplier:<\/strong> MP Biomedicals- Diagnostics
\nWebsite:<\/strong> <\/a><\/p>\n